Pfizer Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 21, 2025
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Limited held its 74th Annual General Meeting on July 21, 2025, at 3:00 PM IST via video conferencing, chaired by Mr. Pradip Shah. The Managing Director presented an overview of Pfizer's 75 years in India, financial highlights, key brand performance, CSR initiatives, ESG efforts, and announced marketing authorization for three new products to be launched in 2025-2026. Shareholders approved the audited financial statements for FY ended March 31, 2025, and the declaration of a dividend of Rs. 165 per equity share (1650%) for the same period. The meeting also covered the re-appointment of Mr. Amit Agarwal as Director, ratification of the Cost Auditor's remuneration, and appointment of M/s. Parikh & Associates as Secretarial Auditors. The meeting concluded at 5:45 PM, with e-voting results to be declared within two working days.
The Rs. 165 per share dividend signals strong cash returns for shareholders, and the announcement of three new product launches in FY26 indicates a growth pipeline. These are positive signals for both income-seeking and growth-oriented investors, though the stock reaction will depend on the actual e-voting results and the detailed financial performance in the annual report.